Behavioral Therapy Development for Methamphetamine Abusers

Inclusion Criteria:

1. HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior
to signing informed consent at the UCLA CARE clinic, aged 18-65

2. Willing to give informed consent and comply with study procedures;

3. Willing to provide consent to contact treating physicians and pharmacies to assess
adherence to HIV medications;

4. Diagnosed with current methamphetamine abuse as determined by MINI; and

5. Interested in seeking treatment for their methamphetamine abuse and in participating
in this research project.

Exclusion Criteria:

1. Unwilling to give, or withdrawal of, informed consent;

2. Inability to understand nature of study;

3. A psychiatric condition that, in the principal investigator's judgment, warrants
additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria
for current bipolar disorder or a psychotic disorder);

4. Current suicidal ideation or suicide attempt within the past 3 months; and

5. Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.

6. Total lack of any type of healthcare coverage. These potential participants will be
given low-fee treatment referrals.